Available Technologies Search

Search Results:

16MA021

Med Device: An Improved Stylet for Endotracheal Tube Placement

07MB004

Antibodies: Use of Antibodies to MARCO for Enhanced Dendritic Cell Vaccine Efficacy

11MA013

Vaccine: Vaccines Using Synthetic Peptide-Poly IC Complexes that Elicit T-cell Responses Comparable to Live Vaccination

14MB098

Cancer Vaccine: Full-Length Variant Survivin Vaccine Potentiates Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

16MA025

TLR9: Targeting Chimeric Antigen Receptor-Expressing T cell (CAR-T) for MDS and AML Immunotherapy

16MB050

AaPC: Artificial Antigen-Presenting Cells for Expanding TILs and MILs in Cancer Immunotherapy

16MB069

IL-13Rα2: Targeting Chimeric Antigen Receptor Expressing T cell (CAR-T) for Melanoma Immunotherapy

17MA007

CD3-CD28: Bispecific Antibody for the Generation of CAR-T cells for Cancer Immunotherapy

17MA012

TILs: Simple and Rapid Method for Culture of TILs from Melanoma Tumor Fragments or Core Needle Biopsies of Solid Tumors

18MA019N

AaPC: Artificial Antigen-Presenting Cells with Heparin-Binding Domain and Protein L for Producing CAR-T Cells

18MB054

Glioma Stem Cell Targeting CAR-T Cell Constructs with Phage Display Derived Peptide Oligomers

18MB059

Brain Mets: Lung Cancer Brain Metastases Targeting CAR-T Cell Constructs with Phage Display Derived Peptide Oligomers

18MB062N

Antibodies: Fully Human anti-LAG3 Antibodies

05B141

Research Tool: Improved Electroporation Buffer for Enhanced Efficiency and Viability

10MA037N

Software: Improved Detection of Lung Function and Management of Lung Cancer Radio Therapy

12MB072

Software: Method for Improving the Accuracy of Charged Particle Beam (High Energy Proton or Carbon Ion Beam) Radiotherapy

13MA025

Software: An Automated Mammographic Density Measure for Improved Breast Cancer Screening

13MB053

Software: BMT Research Analysis Information Network (BRAIN)

13MB073

Software: Decision Support Tool for Oncology Treatment using Mathematical Simulations

14MA004N

Software: Real-time Visualization Software Enables Surgeons to “see-through” the patient and remove tumors more effectively

14MA022

Software: A Quantitative Framework to Identify Radiation Targets for Cancer Treatment that Synergize with Immunotherapy

15MA033

Software: Negative Information Storage Model for Genomic Dat

09MA037

Aurora: Novel Small Molecule Aurora A Kinase Inhibitor as a Cancer Therapeutic

09MB048

pH: Systemic Buffers as Inhibitors of Cancer Metastasis

10MA018N

Mcl-1: Asymmetrical Marinopyrroles as Anti-Cancer Agents

10MA019N

LPAAT: Lysophosphatidic Acid Acyltransferase-Beta Inhibitors to Treat Pancreatic Cancer

10MB048

FT/GGT: Novel Dual Inhibitor of Farnesyltransferase and Geranylgeranyltransferase-1 as an Anti-Cancer Agentbitor

10MB083

Proteasome: Non-covalent and Reversible Proteasome Inhibitors with an Oxadiazole-isopropylamide Core

12MA030

HDAC6: Novel Small Molecule Histone Deacetylase 6 Inhibitor with a Substituted Aryl Urea Cap Group

12MA035N

Mcl-1/Bcl-xL: Cyclic, Symmetrical and Asymmetrical Marinopyrroles as Anti-Cancer Agents

12MB089

IRE-1: Novel Small Molecule Inhibitors of IRE-1 for the Treatment of B-cell Cancer

12MB098

STAT3: Novel Small Molecule STAT3 Inhibitor for Cancer Treatment

12MB110

Novel Symmetrical Marinopyrrole Derivative as a Therapeutic against Resistant Bacterial Strains

14MB069

BRD4 JAK2: Novel BRD4/JAK2 Dual Inhibitors as Cancer Therapeutics

14MB092

WEE1: Small Molecule WEE1 Inhibitor (WEIN-159) that Inhibits WEE1 Phosphorylation of H2B but Not Cdc2 to Treat Can

15MA011

Ras: Small Molecules that Inhibit Mutant KRAS

15MA012

Ras/Raf: Stapled Peptides as Inhibitors of Mutant KRAS

16MA005N

Aurora/JAK2: Dual JAK2 and Aurora A Kinase Inhibitor for GVHD Prophylaxis

17MA014

β-catenin/BCL-9: Small Molecules that Inhibit the β-catenin/BCL9 Interaction

17MB051

XBP-1: XBP-1 Inhibitor B-I09 for the Treatment of Acute GVHD and Solid Organ Rejection

08MA005

Antibody Diagnostic: Monitoring Multiple Myeloma Progression and Recurrence

09MA014

Genetic Signature: Immune-related Gene Signature to Influence Treatment Decisions and Predict Immunotherapy Outcomes in Cancer

10MA024

Molecular Imaging Probe: Breast Cancer-Targeted Probe Set for Improved Detection of Lymph Node Metastases

10MB069N

Molecular Imaging Probe: Fluorescent and MRI Targeted Probes for the Melanocortin Receptor 1 on Melanomas, and Micelle Complexes for Drug Delivery

11MA014

Protein Diagnostic: New Receptor Tyrosine Kinase Assay for Patient Treatment Selection Based on Protein-Protein Bindi

11MA022

Imaging: Digital Pathology Tool to Grade Breast Cancer Histological Images

11MA026N

Molecular Imaging Probe: Surrogate Markers for Colon Adenoma and Adenocarcinoma

11MB064

Molecular Imaging Probe: Synthetic Fluorescent Probe for Improved Detection and Tumor Removal in Pancreatic Cancer Patients

11MB069

Gene Signature for Immunotherapy Response Prediction in Cancer Based on Nuclear Factor-kappa B

11MB087N

Protein Diagnostic: Mass Spectrometry Diagnostic for BRAF and Heat Shock Proteins

12MA069

Genetic Signature: Gene Expression Signature to Determine the Benefit of Adjuvant Chemotherapy in Early Stage Non-Small Cell Lung Cancer

12MB104

Molecular Imaging Probe: A Novel 18F Scaffold for Preparing Targeted PET Imaging Probess

13MA002

Protein Diagnostic: Phosphorylated STAT3 Protein as a Novel Biomarker of Graft Versus Host Disease

13MA009

Multiplex Diagnostic: Detection of Minimal Residual Disease in Multiple Myeloma Using RNA Sequencing and Mass Spectrometry

13MA036

Genetic Signature: Gene Signature Predicts Recurrence and Benefit From Adjuvant Chemotherapy in Colorectal Cancer

13MB047

Imaging: Decision Support Tool for Oncology Treatment that Analyzes Radiological Images

13MB054

Molecular Imaging: Texture Feature Analysis of Low-Dose CT Images for Pulmonary Nodule Diagnosis

13MB055

Molecular Imaging: Novel Imaging Software Diagnostic to Determine Survival in Glioblastoma Multiforme

13MB056N

Molecular Imaging: PET Probes of Radiofluorinated Carboximidamides for IDO-Targeted Imaging

13MB078

miRNA Diagnostic: Blood Based microRNA Assay to Detect Malignant Intraductal Papillary Mucinous Neoplasms (IPMNs)

14MA001

Protein Biomarker: Expression of WEE1 and PAXIP1 Can Select Patients who Respond to WEE1 Inhibitor Therapys

14MA052N

Genetic Signature: Microarray-based Gene Expression Profiling to Predict Tumor Sensitivity to Radiotherapy

15MA015

Molecular Imaging: Monoacylated TLR2 Ligand Fluorescent Probe for Detecti

15MA021N

Diagnostic: Intracellular S100A9 Alone or NLRP3 Inflammasome Activation as MDS Biomarkers

15MA031N

Diagnostic: S100A9 Serum Concentration Levels Predict Lenalidomide Response Duration

15MB042N

Molecular Imaging Probe: In vivo Positron Emission Tomography-Based Perfusion/Blood Pool Imaging Using Labeled Erythrocytes

15MB065

Protein Biomarker: Diagnostic for Progression of MDS to AML Using PD-1 or PD-L1 Expression

16MB040

Genetic Signature: Gene Signature to Distinguish Lung Squamous Cell Carcinoma from Metastatic Head & Neck Squamous Cell Carcinoma

16MB041

Protein Biomarker: Method for Measuring MRE11 in Muscle –Invasive Bladder Cancer to Predict Chemoradiation Response Using AQUA

16MB042

Protein Biomarker: Diagnostic to Determine which Low-Risk MDS Patients to Treat with Lenalidomide to Restore Sensitivity to Erythropoietin

16MB044

Molecular Imaging Probe: Novel IDO1-Targeting Cancer Diagnostic PET Imaging Agent

16MB066

miRNA Diagnostic: MicroRNA Signature to Predict Progression of Barrett’s Esophagus to Esophageal Dysplasia or Adenocarcinoma

17MA025

Genetic Biomarker: PTEN Mutation as a Novel Biomarker of Response to GGTI-2418 Treatment in Cancer

17MB044

Genetic Signature: Gene Signature to Distinguish between Metastatic Urothelial Carcinoma and Squamous Cell Carcinoma (Primary Lung and Metastatic Head & Neck)

10MB054

Med Device: Handheld Radioisotope Identification Device (RIID)

10MB065N

Med Device: Muscle Stapler

11MA017N

Med Device: Pump-assisted High Flow Rate Isolated Limb Infusion for Regional Cancer Treatment

11MA021

Med Device: Minimally Invasive Spinal Fusion Using a Transdiscal Screw System

11MA052

Med Device: Improved Endotracheal Tube to Prevent Intubation-Related Complications Related to Airway Edema (Swelling)

12MA067

Med Device: Improved Arterial Catheter to Prevent Blood Hospital Acquired Infections

13MA001

Med Device: Improved Enteral Feeding Tube and Retention Disc to Reduce Dislodgement, Infection and Complications

13MA030

Med Device: Novel Orogastric Tube Guide for Accurate Placement While Reducing Cross Contamination

14MB067N

Med Device: Expandable Intervertebral Cage for Spinal Fusion

15MA034

Med Device: An Improved Pigtail Drainage Catheter for Percutaneous Fluid Aspiration

15MB067

Med Device: The STAT-Clip Prevents Blood Leakage upon Intra-Venous Catheter Insertion

20MA027 - VIDEO

Olfactory Receptor Targeting Chimeric Antigen Receptor Expressing T cell (CAR-T) for Solid Tumors

20MB046T2

CMG Helicase: Novel Replicative CMG Helicase Inhibitors (CMGi) to Treat Solid Tumors

Count = 88